PortfoliosLab logoPortfoliosLab logo
ISIN
US04537V1052
Issuer
Aspiriant
Inception Date
Apr 3, 2013
Min. Investment
$0
Distribution Policy
Distributing
Asset Class
Equity
Asset Class Size
Large-Cap
Asset Class Style
Blend

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

RMEAX Performance Chart

Aspiriant Risk-Managed Equity Allocation Fund (RMEAX) is up 7.7% since the beginning of the year. RMEAX is currently trading at $18 per share. Investors who bought $1,000 worth of RMEAX shares 5 years ago would now be looking at an investment worth $1,409.


Loading charts...

Benchmark

Compare this symbol against anything

Returns By Period

Aspiriant Risk-Managed Equity Allocation Fund (RMEAX) has returned 7.68% so far this year and 19.18% over the past 12 months. Over the last ten years, RMEAX has returned 8.08% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.


Aspiriant Risk-Managed Equity Allocation Fund

1D
1.04%
1M
0.75%
6M
5.42%
YTD
7.68%
1Y
19.18%
3Y*
11.75%
5Y*
7.10%
10Y*
8.08%
ALL TIME*
7.09%

Benchmark (S&P 500 Index)

1D
0.70%
1M
0.09%
6M
7.94%
YTD
9.41%
1Y
20.07%
3Y*
17.84%
5Y*
11.25%
10Y*
13.26%
ALL TIME*
8.09%
*Multi-year figures are annualized to reflect compound growth (CAGR)

RMEAX Monthly Returns History

Based on dividend-adjusted daily data since Jan 2, 2014, RMEAX's average daily return is +0.03%, while the average monthly return is +0.62%. At this rate, an investment would double in approximately 9.3 years.

Historically, 63% of months were positive and 37% were negative. The best month was Apr 2026 with a return of +7.1%, while the worst month was Mar 2020 at -11.4%. The longest winning streak lasted 14 consecutive months, and the longest losing streak was 4 months.

On a daily basis, RMEAX closed higher 51% of trading days. The best single day was Apr 9, 2025 with a return of +5.8%, while the worst single day was Mar 12, 2020 at -7.4%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20262.15%0.48%-5.87%7.12%3.09%0.06%0.86%7.68%
20253.69%0.37%-2.42%-0.57%3.46%3.47%-0.72%2.77%2.40%0.97%2.10%1.08%17.69%
20241.86%3.32%2.16%-2.12%2.75%2.42%1.31%2.76%1.55%-2.12%2.41%-9.22%6.55%
20234.33%-2.99%2.70%2.56%-0.86%3.96%2.42%-1.55%-2.54%-1.06%5.98%2.72%16.31%
2022-3.21%-3.78%0.48%-4.53%-0.07%-4.82%3.18%-3.15%-7.27%5.22%6.67%-2.30%-13.67%
2021-0.50%1.01%2.94%3.69%1.88%-0.07%1.12%2.02%-3.96%3.79%-2.24%4.54%14.78%

Benchmark Metrics

Aspiriant Risk-Managed Equity Allocation Fund has an annualized alpha of 0.21%, beta of 0.58, and R2 of 0.74 versus S&P 500 Index. Calculated based on daily prices since January 02, 2014.

  • This fund participated in 77.42% of S&P 500 Index downside but only 64.12% of its upside - more exposed to losses than it benefited from rallies.
  • Beta of 0.58 indicates this fund moves significantly less than S&P 500 Index - a genuinely defensive profile with reduced participation in both market rallies and downturns.

Alpha
0.21%
Beta
0.58
0.74
Upside Capture
64.12%
Downside Capture
77.42%

Expense Ratio

RMEAX has an expense ratio of 0.28%, placing it in the medium range.


Return for Risk

Risk / Return Rank

RMEAX ranks 65 for risk / return — above 65% of mutual funds peers on PortfoliosLab. Its historical combined result is above most peers.


RMEAX Risk / Return Rank: 6565
Overall Rank
RMEAX Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
RMEAX Sortino Ratio Rank: 6666
Sortino Ratio Rank
RMEAX Omega Ratio Rank: 6767
Omega Ratio Rank
RMEAX Calmar Ratio Rank: 5353
Calmar Ratio Rank
RMEAX Martin Ratio Rank: 6969
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

Risk / Return Metrics

The table below present risk-adjusted performance metrics for Aspiriant Risk-Managed Equity Allocation Fund (RMEAX) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


RMEAXBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

+0.27

Sortino ratioReturn per unit of downside risk

+0.39

Omega ratioGain probability vs. loss probability

1.31

1.25

+0.05

Calmar ratioReturn relative to maximum drawdown

2.06

2.00

+0.06

Martin ratioReturn relative to average drawdown

9.04

8.49

+0.55

Dividends

Dividend History

Aspiriant Risk-Managed Equity Allocation Fund provided a 10.96% dividend yield over the last twelve months, with an annual payout of $1.92 per share.


0.00%2.00%4.00%6.00%8.00%10.00%12.00%$0.00$0.50$1.00$1.50$2.0020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$1.92$1.92$0.00$0.77$0.28$0.38$0.23$0.64$0.55$0.35$0.25$0.19

Dividend yield

10.96%11.80%0.00%5.30%2.16%2.46%1.64%4.69%4.53%2.67%2.27%1.79%

Monthly Dividends

The table displays the monthly dividend distributions for Aspiriant Risk-Managed Equity Allocation Fund. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2025$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.92$1.92
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.77$0.77
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.28$0.28
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.38$0.38

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Aspiriant Risk-Managed Equity Allocation Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Aspiriant Risk-Managed Equity Allocation Fund was 23.70%, occurring on Mar 20, 2020. Recovery took 180 trading sessions.

The current Aspiriant Risk-Managed Equity Allocation Fund drawdown is 0.23%.


Drawdown

Fall

Recovery

Underwater

Related event

-23.70%Mar 2020
1mo 29d8mo 19d
10mo 18dJan 2020 - Dec 2020
COVID crash2020
-21.79%Oct 2022
9mo 11d1y 2mo
1y 11moJan 2022 - Dec 2023
Bear market2022
-16.49%Apr 2025
3mo 29d5mo 3d
9mo 2dDec 2024 - Sep 2025
2025 selloff2025
-13.86%Feb 2016
8mo 25d6mo 2d
1y 2moMay 2015 - Aug 2016
-11.04%Jan 2019
11mo 9d5mo 18d
1y 4moJan 2018 - Jun 2019

Drawdown Indicators


RMEAXBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-23.70%

-56.78%

+33.08%

Max Drawdown (1Y)

Largest decline over 1 year

-8.41%

-9.10%

+0.69%

Max Drawdown (3Y)

Largest decline over 3 years

-16.49%

-18.90%

+2.41%

Max Drawdown (5Y)

Largest decline over 5 years

-21.79%

-25.43%

+3.64%

Max Drawdown (10Y)

Largest decline over 10 years

-23.70%

-33.92%

+10.22%

Current Drawdown

Current decline from peak

-0.23%

-1.58%

+1.35%

Average Drawdown

Average peak-to-trough decline

-4.21%

-10.70%

+6.49%

Ulcer Index

Depth and duration of drawdowns from previous peaks

1.92%

2.14%

-0.22%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Portfolio Analyzer

Build a portfolio with RMEAX

Add Aspiriant Risk-Managed Equity Allocation Fund to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with RMEAX